Herbert Irving Comprehensive Cancer Center

healthcare

Publications

3,663

Citations

Researchers

Publications

View All

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak , Catherine M. Tangen , Maha Hussain +11 more

The improvement in median survival of nearly two months with docetaxel and estramustine, as compared with mitoxantrone and prednisone, provides support for this approach in men ...

2004 New England Journal of Medicine 3663 citations

Institution Info

Type: healthcare
Country: N/A
Publications: 1
Citations: 3,663

External Links

Identifiers

ROR: https://ror.org/051kc1939

Publications

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Institution Info

External Links

Identifiers

Research Output Over Time